DK0555358T3 - Anthracyclin-analoge med latente alkylsubstituenter - Google Patents

Anthracyclin-analoge med latente alkylsubstituenter

Info

Publication number
DK0555358T3
DK0555358T3 DK91920574.0T DK91920574T DK0555358T3 DK 0555358 T3 DK0555358 T3 DK 0555358T3 DK 91920574 T DK91920574 T DK 91920574T DK 0555358 T3 DK0555358 T3 DK 0555358T3
Authority
DK
Denmark
Prior art keywords
alkyl
alkyl substituents
present
aldehyde
aryl
Prior art date
Application number
DK91920574.0T
Other languages
English (en)
Inventor
David Farquhar
Abdallah Charif
Original Assignee
Univ Texas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Texas filed Critical Univ Texas
Application granted granted Critical
Publication of DK0555358T3 publication Critical patent/DK0555358T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • C07H15/252Naphthacene radicals, e.g. daunomycins, adriamycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
DK91920574.0T 1990-11-01 1991-10-16 Anthracyclin-analoge med latente alkylsubstituenter DK0555358T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/608,149 US5196522A (en) 1990-11-01 1990-11-01 Anthracycline analogues bearing latent alkylating substituents

Publications (1)

Publication Number Publication Date
DK0555358T3 true DK0555358T3 (da) 1994-12-05

Family

ID=24435271

Family Applications (1)

Application Number Title Priority Date Filing Date
DK91920574.0T DK0555358T3 (da) 1990-11-01 1991-10-16 Anthracyclin-analoge med latente alkylsubstituenter

Country Status (9)

Country Link
US (3) US5196522A (da)
EP (1) EP0555358B1 (da)
JP (1) JP3051170B2 (da)
AT (1) ATE109787T1 (da)
AU (1) AU642798B2 (da)
CA (1) CA2094914C (da)
DE (1) DE69103428T2 (da)
DK (1) DK0555358T3 (da)
WO (1) WO1992007866A1 (da)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5196522A (en) * 1990-11-01 1993-03-23 Board Of Regents, The University Of Texas System Anthracycline analogues bearing latent alkylating substituents
US5622929A (en) * 1992-01-23 1997-04-22 Bristol-Myers Squibb Company Thioether conjugates
US6218519B1 (en) 1996-04-12 2001-04-17 Pro-Neuron, Inc. Compounds and methods for the selective treatment of cancer and bacterial infections
US6677309B1 (en) 1997-04-11 2004-01-13 University Technology Corporation Anti-cancer drug aldehyde conjugate drugs with enhanced cytotoxicity compounds, compositions and methods
US20040038904A1 (en) * 2002-05-21 2004-02-26 Angela Ogden Method of treating multiple sclerosis
US20050208037A1 (en) * 2003-10-21 2005-09-22 Board Of Regents, The University Of Texas System Thioredoxin increases redox-cycling of anticancer agents thereby sensitizes cancer cells to apoptosis
US20080132458A1 (en) * 2004-03-10 2008-06-05 Threshold Pharmaceuticals, Inc. Hypoxia-Activated Anti-Cancer Agents
US20070060534A1 (en) * 2005-06-30 2007-03-15 Threshold Pharmaceuticals, Inc. Anthracycline analogs
US7470672B2 (en) * 2006-07-31 2008-12-30 Savvipharm Inc. Compositions and methods of reducing tissue levels of drugs when given as orotate derivatives
US7750018B2 (en) * 2006-12-06 2010-07-06 Tactical Therapeutics, Inc Use of carboxiamidotriazole (CAI) orotate in macular degeneration
EP2538929A4 (en) 2010-02-25 2014-07-09 Univ Johns Hopkins PROLONGED DELIVERY OF THERAPEUTIC AGENTS TO AN OCULAR COMPARTMENT
US10307372B2 (en) 2010-09-10 2019-06-04 The Johns Hopkins University Rapid diffusion of large polymeric nanoparticles in the mammalian brain
WO2012109363A2 (en) 2011-02-08 2012-08-16 The Johns Hopkins University Mucus penetrating gene carriers
CN104936620B (zh) 2012-01-19 2019-08-09 约翰霍普金斯大学 增强粘膜渗透的纳米粒子调配物
CN104363924B (zh) * 2012-03-16 2018-04-17 约翰霍普金斯大学 用于递送hif‑1抑制剂的控制释放调配物
EP2825207B1 (en) 2012-03-16 2020-08-19 The Johns Hopkins University Non-linear multiblock copolymer-drug conjugates for the delivery of active agents
CA2872519C (en) 2012-05-04 2017-09-05 The Johns Hopkins University Lipid-based drug carriers for rapid penetration through mucus linings
US9533068B2 (en) 2012-05-04 2017-01-03 The Johns Hopkins University Drug loaded microfiber sutures for ophthalmic application
US10568975B2 (en) 2013-02-05 2020-02-25 The Johns Hopkins University Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof
CA2895284A1 (en) 2013-02-07 2014-08-14 Immunomedics, Inc. Pro-drug form (p2pdox) of the highly potent 2-pyrrolinodoxorubicin conjugated to antibodies for targeted therapy of cancer
WO2015035002A1 (en) * 2013-09-06 2015-03-12 Vanda Pharmaceuticals Inc. Treatment of cyr61- and vegf-mediated conditions
WO2015127368A1 (en) 2014-02-23 2015-08-27 The Johns Hopkins University Hypotonic microbicidal formulations and methods of use
CN106999517A (zh) 2014-10-07 2017-08-01 免疫医疗公司 抗体‑药物缀合物的新辅助剂用途
WO2016123125A1 (en) 2015-01-27 2016-08-04 The Johns Hopkins University Hypotonic hydrogel formulations for enhanced transport of active agents at mucosal surfaces

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4035566A (en) * 1975-09-25 1977-07-12 Sidney Farber Cancer Institute, Inc. N-trifluoroacetyladriamycin-14-alkanoates and therapeutic compositions containing same
US4109076A (en) * 1977-09-08 1978-08-22 Sri International 5-iminodaunomycin
US4301277A (en) * 1980-10-20 1981-11-17 Sri International 3-Deamino-3-(4-morpholinyl) derivatives of daunorubicin and doxorubicin
US4950738A (en) * 1984-09-13 1990-08-21 Cytogen Corporation Amine derivatives of anthracycline antibiotics
US4464529A (en) * 1982-07-20 1984-08-07 Sri International Analogues of morpholinyl daunorubicin and morpholinyl doxorubicin
US4826964A (en) * 1982-07-20 1989-05-02 Sri International Bridged oxygen analogs of daunorubcin and doxorubicin
US4585859A (en) * 1983-05-24 1986-04-29 Sri International Analogues of morpholinyl daunorubicin and morpholinyl doxorubicin
GB8508508D0 (en) * 1985-04-01 1985-05-09 Creighton A M Pharmaceutical compositions
FR2591599B1 (fr) 1985-12-17 1988-08-05 Hoechst Lab Nouvelles anthracyclines et medicaments les contenant
US5091552A (en) 1986-06-30 1992-02-25 Board Of Regents, The University Of Texas System Novel antitumor aldophosphamide analogs
US4841085A (en) * 1986-06-30 1989-06-20 Board Of Regents, University Of Texas System Aldophosphamides
US5196522A (en) * 1990-11-01 1993-03-23 Board Of Regents, The University Of Texas System Anthracycline analogues bearing latent alkylating substituents

Also Published As

Publication number Publication date
EP0555358B1 (en) 1994-08-10
DE69103428D1 (de) 1994-09-15
US6433150B2 (en) 2002-08-13
DE69103428T2 (de) 1995-03-30
US6284737B1 (en) 2001-09-04
CA2094914C (en) 1998-02-10
ATE109787T1 (de) 1994-08-15
WO1992007866A1 (en) 1992-05-14
JPH06502417A (ja) 1994-03-17
EP0555358A1 (en) 1993-08-18
US20010053845A1 (en) 2001-12-20
JP3051170B2 (ja) 2000-06-12
CA2094914A1 (en) 1992-05-02
US5196522A (en) 1993-03-23
AU642798B2 (en) 1993-10-28
AU9029291A (en) 1992-05-26

Similar Documents

Publication Publication Date Title
DK0555358T3 (da) Anthracyclin-analoge med latente alkylsubstituenter
DE69200396D1 (de) Kosmetische Zubereitung.
OA06625A (fr) Nouvelles benzophénone hydrazones, leur procédé de préparation et leur application comme pesticides.
PT757677E (pt) Derivados de benzociclohexilimidazoletiona
SE8801514L (sv) Farmaceutisk komposition
ES8704445A1 (es) Procedimiento de preparar derivados aminicos
ES2186297T3 (es) Procedimiento para la preparacion de derivados de imidazoquinazolinona.
ES543998A0 (es) Un procedimiento para la preparacion de nuevos derivados de bistriazol
ES549298A0 (es) Un procedimiento para la preparacion de derivados de triazol
DK0536197T3 (da) Ren, krystallinsk form af rifapentine
FR2360578A1 (fr) Diacrylates de derives de l'hydantoine et leurs applications comme resines et adhesifs
PT94078A (pt) Processo para a preparacao de derivados de acido butenoico e de composicoes farmaceuticas que os contem
FR2397836A1 (fr) Derives de l'oxo-1-dihydro-1,2-isoquinoleine utilises comme agents anti-inflammatoires analgesiques forts
DE3361268D1 (de) 2,2-dihalogen-3,3-dimethyl-cyclopropane derivatives
FR2427325A1 (fr) Derives de l'alanine possedant des proprietes fongicides, leur preparation et leurs utilisations
FR2418229A1 (fr) Nouveaux sels de 5-phenyl-2-oxazolecarboximidamides, utiles notamment comme antidepressifs
JPS545924A (en) Derivative of butylaldeyde and its preparation
DK221786D0 (da) Phosphorimidater, deres fremstilling og anvendelse til bekaempelse af insekter, mider og nematoder
BE838588A (fr) Derives de polysaccharides